Editorial
doi: 10.1007/s10198-015-0683-z.
When do performance-based risk-sharing arrangements make sense?
Affiliations
- PMID: 25783211
- DOI: 10.1007/s10198-015-0683-z
Item in Clipboard
Editorial
When do performance-based risk-sharing arrangements make sense?
Eur J Health Econ.
2015 Jul.
No abstract available
Similar articles
-
Performance-Based Risk-Sharing Arrangements: An Updated International Review.Pharmacoeconomics. 2017 Oct;35(10):1063-1072. doi: 10.1007/s40273-017-0535-z. Pharmacoeconomics. 2017. PMID: 28695544 Review.
-
Performance-based risk-sharing arrangements-good practices for design, implementation, and evaluation: report of the ISPOR good practices for performance-based risk-sharing arrangements task force.Value Health. 2013 Jul-Aug;16(5):703-19. doi: 10.1016/j.jval.2013.04.011. Epub 2013 Jul 19. Value Health. 2013. PMID: 23947963
-
Where are we on "risk-sharing" agreements?Value Health. 2013 Jul-Aug;16(5):701-2. doi: 10.1016/j.jval.2013.04.012. Epub 2013 Jun 14. Value Health. 2013. PMID: 23947962 No abstract available.
-
USING CLAIMS DATA FOR EVIDENCE GENERATION IN MANAGED ENTRY AGREEMENTS.Int J Technol Assess Health Care. 2016 Jan;32(1-2):69-77. doi: 10.1017/S0266462316000131. Epub 2016 Mar 15. Int J Technol Assess Health Care. 2016. PMID: 26975757
-
Emerging roles for pharmacists in performance-based risk-sharing arrangements.Am J Health Syst Pharm. 2017 Jul 1;74(13):1007-1012. doi: 10.2146/ajhp160398. Epub 2017 May 18. Am J Health Syst Pharm. 2017. PMID: 28522641 Review. No abstract available.
Cited by
-
The economics of alternative payment models for pharmaceuticals.Eur J Health Econ. 2021 Jun;22(4):559-569. doi: 10.1007/s10198-021-01274-4. Epub 2021 Mar 16. Eur J Health Econ. 2021. PMID: 33725260 Free PMC article.
-
An evaluation of managed access agreements in England based on stakeholder experience.Int J Technol Assess Health Care. 2023 Jul 27;39(1):e55. doi: 10.1017/S0266462323000478. Int J Technol Assess Health Care. 2023. PMID: 37497570 Free PMC article.
-
Incentivizing research into the effectiveness of medical devices.Eur J Health Econ. 2016 Dec;17(9):1055-1058. doi: 10.1007/s10198-016-0820-3. Eur J Health Econ. 2016. PMID: 27492637 No abstract available.
-
Performance-Based Risk-Sharing Arrangements: An Updated International Review.Pharmacoeconomics. 2017 Oct;35(10):1063-1072. doi: 10.1007/s40273-017-0535-z. Pharmacoeconomics. 2017. PMID: 28695544 Review.
-
Issues, Challenges and Opportunities for Economic Evaluations of Orphan Drugs in Rare Diseases: An Umbrella Review.Pharmacoeconomics. 2024 Jun;42(6):619-631. doi: 10.1007/s40273-024-01370-2. Epub 2024 Apr 14. Pharmacoeconomics. 2024. PMID: 38616217 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
